Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel

被引：1

作者：

Mian, Agrima ^{[1
]}

Wei, Wei ^{[2
]}

Hamilton, Betty K. ^{[3
]}

Winter, Allison M. ^{[3
]}

Khouri, Jack ^{[3
]}

Pohlman, Brad ^{[3
]}

Gerds, Aaron T. ^{[3
]}

Jagadeesh, Deepa ^{[3
]}

Anwer, Faiz ^{[3
]}

Kalaycio, Matt ^{[3
]}

Dean, Robert M. ^{[3
]}

Sobecks, Ronald ^{[3
]}

Caimi, Paolo F. ^{[3
]}

Hill, Brian T. ^{[3
]}

Majhail, Navneet S. ^{[4
]}

机构：

[1] Cleveland Clin, Dept Internal Med, Cleveland, OH USA

[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA

[3] Cleveland Clin, Dept Hematol & Med Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA

[4] Sarah Cannon, Nashville, TN 37203 USA

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 05期

关键词：

TRANSPLANTATION; OUTCOMES; THERAPY;

D O I：

10.1038/s41409-023-01934-4

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：590 / 593

页数：4

共 50 条

[31] Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Choe, Jee H.
Abdel-Azim, Hisham
Padula, William, V
Abou-El-Enein, Mohamed
JAMA NETWORK OPEN, 2022, 5 (12)
[32] Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma
Oluwole, Olalekan O.
Jansen, Jeroen P.
Lin, Vincent W.
Chan, Keith
Keeping, Sam
Navale, Lynn
Locke, Frederick L.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) : 1581 - 1588
[33] Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis
Gagelmann, Nico
Bishop, Michael
Ayuk, Francis
Bethge, Wolfgang
Glass, Bertram
Sureda, Anna
Pasquini, Marcelo C.
Kroeger, Nicolaus
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (06): : 584.e1 - 584.e13
[34] Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Olalekan O. Oluwole
Edouard Forcade
Javier Muñoz
Sophie de Guibert
Julie M. Vose
Nancy L. Bartlett
Yi Lin
Abhinav Deol
Peter McSweeney
Andre H. Goy
Marie José Kersten
Caron A. Jacobson
Umar Farooq
Monique C. Minnema
Catherine Thieblemont
John M. Timmerman
Patrick Stiff
Irit Avivi
Dimitrios Tzachanis
Yan Zheng
Saran Vardhanabhuti
Jenny Nater
Rhine R. Shen
Harry Miao
Jenny J. Kim
Tom van Meerten
Bone Marrow Transplantation, 2024, 59 : 366 - 372
[35] Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
Shapiro, Lauren C.
Mustafa, Jennat
Lombardo, Amanda
Khatun, Fariha
Joseph, Felisha
Gillick, Kailyn
Naik, Anjali
Elkind, Richard
Abreu, Michelly
Fehn, Karen
de Castro, Alyssa
Pradhan, Kith
Binakaj, Donika
Nelson, Randin
Paroder, Monika
Uehlinger, Joan
Gritsman, Kira
Alejandro Sica, R.
Kornblum, Noah
Shastri, Aditi
Mantzaris, Ioannis
Bachier-Rodriguez, Lizamarie
Verma, Amit
Braunschweig, Ira
Goldfinger, Mendel
BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1761 - 1763
[36] Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion
Gouni, Sushanth
Westin, Jason R.
Mistry, Haleigh
Steiner, Raphael Eric
James, Jinsu
Parmar, Simrit
Noorani, Mansoor
Fowler, Nathan H.
Horowitz, Sandra B.
Feng, Lei
Fayad, Luis E.
PIyer, Swaminathan
Green, Michael R.
Hawkins, Misha
Flowers, Christopher R.
Ahmed, Sairah
Nastoupil, Loretta
Neelapu, Sattva S.
Nieto, Yago
Strati, Paolo
BLOOD, 2021, 138
[37] Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids
Oluwole, Olalekan O.
Forcade, Edouard
Munoz, Javier
de Guibert, Sophie
Vose, Julie M.
Bartlett, Nancy L.
Lin, Yi
Deol, Abhinav
McSweeney, Peter
Goy, Andre H.
Kersten, Marie Jose
Jacobson, Caron A.
Farooq, Umar
Minnema, Monique C.
Thieblemont, Catherine
Timmerman, John M.
Stiff, Patrick
Avivi, Irit
Tzachanis, Dimitrios
Zheng, Yan
Vardhanabhuti, Saran
Nater, Jenny
Shen, Rhine R.
Miao, Harry
Kim, Jenny J.
van Meerten, Tom
BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 366 - 372
[38] Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Bharadwaj, Sushma
Lau, Eric
Hamilton, Mark P.
Goyal, Anmol
Srinagesh, Hrishi
Jensen, Alexandria
Lee, Dasom
Mallampet, Jayasindhu
Elkordy, Sarah
Syal, Shriya
Patil, Sunita
Latchford, Theresa
Sahaf, Bita
Arai, Sally
Johnston, Laura J.
Lowsky, Robert
Negrin, Robert
Rezvani, Andrew R.
Shizuru, Judith
Meyer, Everett H.
Shiraz, Parveen
Mikkilineni, Lekha
Weng, Wen-Kai
Smith, Melody
Sidana, Surbhi
Muffly, Lori
Maecker, Holden T.
Frank, Matthew J.
Mackall, Crystal
Miklos, David
Dahiya, Saurabh
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
[39] Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
Ionescu, Filip
Shah, Bijal D.
Menges, Meghan
Reid, Kayla
Bailey, Hanna
DiMaggio, Elizabeth
Gonzalez, Rebecca
Bachmeier, Christina A.
Corallo, Salvatore
Delgado, Luis Cuadrado
Mohammed, Turab
Nishihori, Taiga
Khimani, Farhad
Lazaryan, Aleksandr
Liu, Hien
Davila, Marco
Perna, Fabiana
Chavez, Julio C.
Locke, Frederick L.
Jain, Michael D.
BLOOD, 2023, 142
[40] Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma
Baird, John H.
Epstein, David J.
Tamaresis, John S.
Ehlinger, Zachary
Spiegel, Jay Y.
Craig, Juliana
Claire, Gursharan K.
Frank, Matthew J.
Muffly, Lori
Shiraz, Parveen
Meyer, Everett
Arai, Sally
Brown, Janice
Johnston, Laura
Lowsky, Robert
Negrin, Robert S.
Rezvani, Andrew R.
Weng, Wen-Kai
Latchford, Theresa
Sahaf, Bita
Mackall, Crystal L.
Miklos, David B.
Sidana, Surbhi
BLOOD ADVANCES, 2021, 5 (01) : 143 - 155

← 1 2 3 4 5 →